Watch

CAPRCapricor Therapeutics, Inc.

Healthcare · Biotechnology · small-cap ($1.7B)
-27.9%
from rolling 252-day high of $40.37 set 2025-12-03 · 176d ago
Current
$29.11
Decline depth
-27.9%
Decline σ
3.6σ
TFC
1/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$CAPR landed on the list 2026-03-02, down 33.5% from its 52-week high that day — now down -27.9%.

That's 1.0 percentage points deeper than the day it joined. It bottomed 38.0% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

CAPR qualifies for the Watch on decline depth.

Decline depth
-27.9%
From rolling 252-day high of $40.37, 176d ago. Past the 20% Watch threshold.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
3.6σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (4.73% per day).

The structural read

What price action says about CAPR.

CAPR qualifies for the Watch on decline depth — down -27.9% from its rolling 252-day high.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 1 (red), monthly 2D (red).

Earnings on file: 2026-05-12. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $4.30 68.8% of range 52W high $40.37

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

89 Red List
47 Amber
58 Watch
-36.0% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about CAPR

What people ask.

Why is CAPR on Broken Stocks?

CAPR qualifies for the Watch on decline depth. It is down -27.9% from its rolling 252-day high of $40.37, set on 2025-12-03 — 176d ago.

Is CAPR a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. CAPR is down -27.9% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is CAPR a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CAPR trading inside its 52-week range?

At $29.11, CAPR sits 68.8% of the way from its 52-week low ($4.30) to its 52-week high ($40.37). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CAPR been declining?

The current 27.9% decline accrued over 176d, which annualizes to roughly -57.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CAPR compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 47 Amber, 58 Watch, with 108 showing recovering structural signals. Median sector decline is -36.0% — CAPR's decline is shallower than the sector median.

Does CAPR's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-12) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.